Onward Medical N.V. (ONWRF)
OTC Markets OTCQX · USD · Healthcare · Biotechnology
$2.31 (-14.76%) as of
Key statistics
- Market cap
- 160.61M
- EPS (TTM)
- -0.9900
- Dividend yield
- 0.00%
- 52-week range
- 2.3100 – 5.7000
- Beta
- 0.81
- Revenue (TTM)
- 8.42M
- Profit margin
- 0.00%
- Volume
- 400.00
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Eindhoven, Netherlands
- Employees
- 137
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.